The BioAct brand, founded in 2002 (Germany), from 2081 sister brands and 17477 competing brands. BioAct is owned by BAYER, listed on the stock exchange of Francfort The ISIN, the company's International Securities Identification Number, is DE000BAY0017. The sector of BioAct is Drug Manufacturers.
Investment simulator :
Portfolio valuation
BAYER
(BioAct)
over 5 years*
EUR 12.02